5 results about "Scutellaria barbata" patented technology

This invention belongs to the field of gastric disease treatment, specifically relating to a traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and its preparation method. The traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia comprises the following raw materials in parts by weight: Agrimonia pilosa 10-15 parts, Cyperus rotundus 8-10 parts, Scutellaria barbata 10-15 parts, Lobelia chinensis 10-15 parts, Patrinia scabiosaefolia 13-17 parts, Scutellaria baicalensis 7-11 parts, Hedyotis diffusa 10-15 parts, Prunella vulgaris 10-15 parts, Hedyotis diffusa 5-7 parts, Perilla frutescens 8-10 parts, Coptis chinensis 5-7 parts, Angelica sinensis 5-7 parts, etc. This invention focuses on the core pathogenesis of damp-heat in the spleen and stomach and stagnation of gastric collaterals. The Chinese herbal composition has the effects of clearing heat and removing dampness, regulating qi and harmonizing the stomach, nourishing blood and unblocking collaterals. Clinically, it can significantly improve the OLGA / OLGIM stage of patients with chronic atrophic gastritis with intestinal metaplasia, with a total effective rate of 65.1%, providing a safe and effective Chinese medicine solution for precancerous lesions of the stomach.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition for treating tinnitus. Its ingredients include: vinegar-processed turtle shell, stir-fried jujube seed, anemarrhena rhizome, phellodendron bark, rehmannia root, white peony root, poria cocos, fleeceflower root vine, scutellaria barbata, oldenlandia diffusa, stir-fried atractylodes macrocephala, prunella vulgaris, and cicada slough. The TCM composition of this invention exhibits significant multi-dimensional beneficial effects in treating tinnitus. Compared with Western medicine treatments, it avoids the side effects such as low blood pressure, dizziness, drowsiness, and dry mouth associated with vasodilators and antidepressants, and overcomes the drawbacks of physical therapy, which only temporarily relieves symptoms and cannot cure the condition. It has the advantages of holistic conditioning and fewer side effects, providing a safe, effective, and comprehensive treatment plan for tinnitus patients, and has high clinical application value and promotional significance.

This invention relates to the field of traditional Chinese medicine composition technology, and in particular to a traditional Chinese medicine composition for treating lung cancer and its preparation method, comprising composition one, composition two, and composition three; composition one, by weight parts, comprises: Astragalus membranaceus 20-45 parts, Polygonatum odoratum 15-30 parts, Ophiopogon japonicus 8-18 parts, Coix lacryma-jobi 20-45 parts, Phragmites communis 20-45 parts, and Glycyrrhiza uralensis 3-6 parts; composition two, by weight parts, comprises: Clematis armandii 9-15 parts, Actinidia chinensis root 15-30 parts, Scutellaria barbata 10-22 parts, Pinellia ternata 6-13 parts, Fritillaria thunbergii 6-13 parts, and Citrus reticulata peel 6-13 parts; composition three, by weight parts, comprises: Buthus martensii 3-8 parts. The traditional Chinese medicine composition prepared by this invention has the effects of invigorating qi and nourishing yin, clearing heat and detoxifying, resolving phlegm and dissipating nodules, and promoting blood circulation and unblocking collaterals. It overcomes the technical problems of existing anti-lung cancer chemotherapy drugs having large toxic side effects and easily developing drug resistance, as well as the limited anti-lung cancer effects of existing single or simple compound traditional Chinese medicines, and the lack of optimization in compatibility and process.

This invention discloses a traditional Chinese medicine formula for reducing toxicity and enhancing efficacy in combination with chemotherapy and immunotherapy for non-small cell lung cancer, belonging to the field of traditional Chinese medicine technology. The formula is composed of the following components by weight: Astragalus membranaceus 15-30 parts, Codonopsis pilosula 9-15 parts, Coix lacryma-jobi 15-30 parts, Poria cocos 9-15 parts, Atractylodes macrocephala (stir-fried with wheat bran) 9-15 parts, Citrus reticulata 9-15 parts, Hedyotis diffusa 15-30 parts, Scutellaria barbata 15-30 parts, Selaginella tamariscina 15-30 parts, Hedyotis diffusa 15-30 parts, Prunella vulgaris 9-15 parts, Gallus gallus domesticus (gizzard lining) 10-15 parts, stir-fried Hordeum vulgare 9-15 parts, stir-fried Hordeum vulgare 9-15 parts, and Glycyrrhiza uralensis (processed with honey) 3-6 parts. This invention can synergize with chemotherapy and immunotherapy to improve treatment efficacy and prolong survival, thus overcoming the shortcomings of existing treatments. At the same time, as a traditional Chinese medicine formula, it can significantly reduce the toxic side effects of treatment, improve the body's immune status, and relieve symptoms such as cough and chest tightness, thereby improving the patient's quality of life from multiple dimensions such as efficacy, tolerability, and physical sensation.